AU2003212375A1 - Use of ltb4 antagonists in veterinary medicine - Google Patents

Use of ltb4 antagonists in veterinary medicine

Info

Publication number: AU2003212375A1
Authority: AU; Australia
Prior art keywords: veterinary medicine; ltb4 antagonists; ltb4; antagonists; veterinary
Prior art date: 2002-03-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003212375A

Inventor

Franz Birke

Kandace Matzek

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Boehringer Ingelheim Pharma GmbH and Co KG

Original Assignee

Boehringer Ingelheim Pharma GmbH and Co KG

Boehringer Ingelheim Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-26

Filing date

2003-03-24

Publication date

2003-10-08

2003-03-24 Application filed by Boehringer Ingelheim Pharma GmbH and Co KG, Boehringer Ingelheim Pharmaceuticals Inc filed Critical Boehringer Ingelheim Pharma GmbH and Co KG

2003-10-08 Publication of AU2003212375A1 publication Critical patent/AU2003212375A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Pulmonology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AU2003212375A 2002-03-26 2003-03-24 Use of ltb4 antagonists in veterinary medicine Abandoned AU2003212375A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE10213350A DE10213350A1 (en)	2002-03-26	2002-03-26	Use of LTB¶4¶ antagonists in veterinary medicine
DE10213350.6		2002-03-26
PCT/EP2003/003021 WO2003080037A2 (en)	2002-03-26	2003-03-24	Use of ltb4 antagonists in veterinary medicine

Publications (1)

Publication Number	Publication Date
AU2003212375A1 true AU2003212375A1 (en)	2003-10-08

Family

ID=28050833

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003212375A Abandoned AU2003212375A1 (en)	2002-03-26	2003-03-24	Use of ltb4 antagonists in veterinary medicine

Country Status (10)

Country	Link
EP (1)	EP1490042A2 (en)
JP (1)	JP2005529085A (en)
AR (1)	AR039141A1 (en)
AU (1)	AU2003212375A1 (en)
CA (1)	CA2480032A1 (en)
DE (1)	DE10213350A1 (en)
PE (1)	PE20030947A1 (en)
TW (1)	TW200407109A (en)
UY (1)	UY27731A1 (en)
WO (1)	WO2003080037A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN110869362A (en)	2017-05-12	2020-03-06	国立研究开发法人理化学研究所	Modified class A GPCR binding compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5246965A (en) *	1991-06-11	1993-09-21	Ciba-Geigy	Arylethers, their manufacture and methods of treatment
ZA929051B (en) *	1991-11-25	1994-05-23	Lilly Co Eli	Substituted phenyl phenol leukotriene antagonists
DE19636689A1 (en) *	1996-09-10	1998-03-12	Boehringer Ingelheim Kg	New benzamidine derivatives
US6291531B1 (en) *	1999-10-07	2001-09-18	Boehringer Ingelheim Pharma Kg	LTB4 antagonist, processes for the preparation thereof and its use as a pharmaceutical composition

2002
- 2002-03-26 DE DE10213350A patent/DE10213350A1/en not_active Withdrawn
2003
- 2003-03-24 EP EP03708263A patent/EP1490042A2/en not_active Withdrawn
- 2003-03-24 TW TW092106507A patent/TW200407109A/en unknown
- 2003-03-24 AU AU2003212375A patent/AU2003212375A1/en not_active Abandoned
- 2003-03-24 PE PE2003000289A patent/PE20030947A1/en not_active Application Discontinuation
- 2003-03-24 JP JP2003577866A patent/JP2005529085A/en active Pending
- 2003-03-24 UY UY27731A patent/UY27731A1/en not_active Application Discontinuation
- 2003-03-24 CA CA002480032A patent/CA2480032A1/en not_active Abandoned
- 2003-03-24 WO PCT/EP2003/003021 patent/WO2003080037A2/en not_active Ceased
- 2003-03-26 AR ARP030101046A patent/AR039141A1/en unknown

Also Published As

Publication number	Publication date
WO2003080037A3 (en)	2004-06-10
WO2003080037A2 (en)	2003-10-02
EP1490042A2 (en)	2004-12-29
CA2480032A1 (en)	2003-10-02
DE10213350A1 (en)	2003-10-16
TW200407109A (en)	2004-05-16
AR039141A1 (en)	2005-02-09
JP2005529085A (en)	2005-09-29
UY27731A1 (en)	2003-10-31
PE20030947A1 (en)	2004-01-13

Publication	Publication Date	Title
AU2003252478A1 (en)	2004-02-02	Ccr4 antagonist and medicinal use thereof
AU2003288994A1 (en)	2004-06-30	Nitrogen-containing heterocyclic compounds and medicinal use thereof
AU2003262262A1 (en)	2004-03-19	Pyrazole derivatives, medicinal composition containing the same, and medicinal use thereof
IL176248A0 (en)	2006-10-05	N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
IL164463A (en)	2011-09-27	Use of osteoprotegerin in the preparation of medicaments
AU2003255645A1 (en)	2003-12-22	Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
AU2002950853A0 (en)	2002-09-12	Aminopyrimidine compound and pharmaceutical use thereof
AU2003269018A1 (en)	2004-02-09	Acylaminothiazole derivatives, preparation and therapeutic use thereof
IL149377A0 (en)	2009-02-11	Pharmaceutical formulation comprising melatonin
GB0615918D0 (en)	2006-09-20	Composition and its therapeutic use
GB0207411D0 (en)	2002-05-08	Azole compounds and their therapeutic use
PL375309A1 (en)	2005-11-28	Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof
AU2003212375A1 (en)	2003-10-08	Use of ltb4 antagonists in veterinary medicine
AU2003240052A1 (en)	2003-12-12	Il-11 derivatives and therapeutic uses thereof
AU2003215767A1 (en)	2003-10-08	Devices for use in medicine
AU2003235887A1 (en)	2003-11-11	Bislactone derivative and use thereof in medicinal composition
AU2003240446A1 (en)	2003-10-13	Use of mob-5 in pain
AU2003264474A1 (en)	2004-04-08	Novel uracil derivatives and medicinal use thereof
GB0312844D0 (en)	2003-07-09	Use of compounds in medicine
AUPS092602A0 (en)	2002-03-28	Pyrazolopyridine compound and pharmaceutical use thereof
AU2003238900A8 (en)	2003-12-22	Pharmaceutical formulation
HK1094331A (en)	2007-03-30	N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
HK1069324A (en)	2005-05-20	Low dose liquid entecavir formulations and use
AU2003268724B2 (en)	2007-02-22	Isoquinoline compounds and medicinal use thereof
IL165420A0 (en)	2006-01-15	Piperazinylacylpiperidine derivatives their preparation and therapeutic use thereof

Legal Events

Date	Code	Title	Description
2004-12-16	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase